Personalis®

In the News

Discover the latest news and other related articles

Personalis in the News 2016-12-03T06:23:59+00:00

The following articles provide background information about Personalis’ technologies and founders. For additional information, see our extensive list of peer-reviewed publications.

1 2 3 6
March152017

Genomics Brings Heavy Lifting to Immuno-Oncology

The use of genomics in immuno-oncology is really exploding,” remarked Richard Chen, M.D., chief scientific officer at Personalis, a precision-medicine company utilizing next-generation sequencing-based clinical diagnostics.
February032017

GenomeWeb: Personalis Report Highlights Challenges in Variant Annotation

In a report in Genome Medicine last week, researchers from human genome sequencing firm Personalis shared results from their comparison of different tools for translating genomic variant data into a syntax that can be referenced across legacy transcriptomic or proteomic reports. Overall, they found there was "significant inconsistency," both from tool to tool and in comparison to existing databases.
December162016

Argos Therapeutics Enters into Strategic Research Agreement with Personalis, Inc.

Personalis to support ongoing research efforts to demonstrate that Argos’ lead product candidate, rocapuldencel-T, specifically targets patients’ tumor-specific neoantigens without the need to identify them first.
December012016

Sean Parker's big push to hack cancer takes aim at tumor ‘tags'

"This effort will help us continue to hone the neoantigen prediction methods we are using in our neoantigen-based personalized cancer vaccines partnerships and immunotherapy diagnostics," Dr. Richard Chen, Personalis' chief scientific officer said in an email to the San Francisco Business Times. "This work has the potential to be truly transformative.”
July162015
April072015
March112015
March102015
March102015

Quest Diagnostics to Enhance Diagnosis of Pediatric Neurological Disorders with Exclusive Whole Exome Sequencing from Personalis

Proprietary Neurome™ service provides insight into the genetic causes of neurological disorders so parents and health care providers can develop personalized care strategies
December102014

Advances in Exome Sequencing

Next-generation sequencing has facilitated an explosion in clinical genetic testing, and for some patients with unknown disorders for which there were previously no genetic tests available, exome sequencing is now an option.
1 2 3 6